HONOLULU – At its monthly meeting held yesterday at Honolulu Community College, the University of Hawaiʻi Board of Regents approved the bachelor of arts in pharmacy studies and the doctorate in pharmaceutical sciences as provisional programs to be administered by the College of Pharmacy at the University of Hawai‘i at Hilo, effective fall 2011.
The UH Hilo College of Pharmacy currently offers a curriculum leading to the doctor of pharmacy (PharmD) with the first class of student pharmacists scheduled to graduate in May 2011. The addition of the bachelor of arts in pharmacy studies (BAPS) will give the College of Pharmacy an additional advantage over programs that do not offer such a degree and will make the program even more attractive to applicants. Implementation of the doctorate in pharmaceutical sciences will also give the College of Pharmacy a distinct competitive advantage through research excellence and prepare graduates to be scientists with extensive skills in research design, techniques and methodologies.
“Each of these programs expands our ability to offer students more options in a changing world landscape,” said College of Pharmacy Dean John M. Pezzuto. “The BAPS degree will enhance educational opportunities for our PharmD students and make them more competitive in the marketplace. The doctorate in pharmaceutical sciences complements the PharmD program by exposing students to career prospects beyond the practice of pharmacy. We’ve been building these degree options since the founding of the college.”
The BAPS degree is designed for students enrolled in the PharmD program at the UH Hilo College of Pharmacy. Students who enter the PharmD program at UH Hilo are required to have met pre-pharmacy requirements, but they are not required to have earned a bachelor’s degree. The PharmD curriculum is rigorous and requires four years of studies, surpassing the requirements of a bachelor’s level degree. By providing the BAPS degree option, students will have the opportunity to have their academic achievements properly recognized.
The program supports the Hawai‘i Graduation Initiative of the UH System, which aims to increase the number of UH graduates by 25 percent by 2015. The degree offering will also increase UH Hilo retention rates, as students who participate in the pre-pharmacy program will earn a bachelor’s degree.
The doctorate in pharmaceutical sciences will be the first program of this type to be offered by the University of Hawai‘i, and the only program of this nature to be offered in the state of Hawai‘i and the Pacific region. It will significantly elevate the culture of research, development and technology transfer in the pharmaceutical sciences, with an emphasis on natural products discovery and development and their importance in pharmacy and healthcare in general. This effort is consistent with the UH System’s focus on workforce development and research innovation in contribution to Hawai‘i’s overall economic future.
“Not only will residents of Hawai‘i be able to earn a doctorate in pharmaceutical science without leaving the state, but we will also be able to attract scholars from the mainland and abroad with unparalleled opportunities. The economic and intellectual benefits to the state reach far beyond our imagination at this point,” said Pezzuto.